Santa Fe Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Santa Fe Partners’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7,471	Closed	-$3.47M	–	558
2015 Q3	$3.47M	Buy	7,471 +3,498	+88%	+$1.88M	0.46%	66
2015 Q2	$2.03M	Buy	3,973 +1,887	+90%	+$921K	0.28%	141
2015 Q1	$941K	Sell	2,086 -3,306	-61%	-$1.4M	0.11%	315
2014 Q4	$2.21M	Buy	5,392 +3,787	+236%	+$1.49M	0.28%	138
2014 Q3	$578K	Sell	1,605 -1,581	-50%	-$530K	0.09%	360
2014 Q2	$901K	Sell	3,186 -1,401	-31%	-$415K	0.13%	284
2014 Q1	$1.38M	Sell	4,587 -2,314	-34%	-$713K	0.2%	208
2013 Q4	$1.9M	Buy	+6,901	New	+$1.98M	0.31%	127
2013 Q3	–	Sell	-10,501	Closed	-$2.36M	–	563
2013 Q2	$2.36M	Buy	+10,501	New	+$2.45M	0.48%	32

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Santa Fe Partners's REGN Position: Q4 2015 in Review

Santa Fe Partners sold out of Regeneron Pharmaceuticals (REGN) in Q4 2015, closing a stake of 7,471 shares — an estimated $3.47M sold.

Santa Fe Partners first reported a position in REGN in Q2 2013 and held it in 9 quarters. The position peaked at $3.47M in Q3 2015. 575 funds tracked by Wall St. Rank hold REGN as of Q4 2015.

Santa Fe Partners reported no remaining Regeneron Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Santa Fe Partners sold 7,471 Regeneron Pharmaceuticals shares in Q4 2015, an estimated $3.47M.
Santa Fe Partners first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 9 quarters.
Santa Fe Partners's Regeneron Pharmaceuticals position peaked at $3.47M in Q3 2015.
575 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2015.

Based on Santa Fe Partners's 13F filing for Q4 2015, filed 12 Feb 2016.